Evoke Pharma Inc
EVOK
Delayed Nasdaq - 10/20 10:00:00 pm
3.44USD
+2.08%
Upcoming events
11/15/17
Q3 2017 Earnings Release (Projected)
Past Events
10/11/17Oppenheimer & Co. Specialty Pharmaceuticals Conference - One-on-One Meetings
09/12/17 | 04:00pmRodman & Renshaw Global Investment Conference
08/14/17 | 10:30pmInterim 2017 Earnings Call
08/14/17Interim 2017 Earnings Release
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread




Operating income (EBITDA)
Million $
Released
Forecast
Spread
-10,5
-9,20
-15%

-10,4
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-10,5
-10,2
-3,5%

-11,3
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-10,7
-11,6
7,0%

-13,1
Net income
Million $
Released
Forecast
Spread
-10,7
-11,3
5,0%

-13,1
EPS
 $
Released
Forecast
Spread
-1,15
-1,28
9,9%

-0,87
Announcement Date03/15/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread




Operating income (EBITDA)
Million $
Released
Forecast
Spread
-2,89
-2,40
-20%

-2,70
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-2,89
-2,23
-30%

-3,03
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-1,63
-2,20
26%

-3,05
Net income
Million $
Released
Forecast
Spread
-1,63
-2,20
26%

-3,05
EPS
 $
Released
Forecast
Spread
-0,11
-0,15
27%

-0,20
Announcement Date08/14/2017
Operating profit - Rate of surprise
EPS - Rate of surprise